SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences informs about 36th AGM

23 Aug 2023 Evaluate
Pursuant to regulation 34(1) of SEBI (LODR) Regulations, 2015, Hester Biosciences has submitted the Annual Report of the Company along with the Notice of the 36th Annual General Meeting for the financial year 2022-23, which is being sent to the members of the Company through the electronic means as per the circulars issued by the MCA and SEBI. 36th Annual General Meeting schedule to be held on Wednesday, 20 September 2023 through Video Conference / Other Audio-Visual Means. Wednesday, 13 September 2023 will be the Cut-off Date for the purpose of determining the members eligible to vote on the resolutions set out in the Notice of the AGM or to attend the AGM.

The above information is a part of company’s filings submitted to BSE. 

Hester Biosciences Share Price

1492.80 20.80 (1.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×